Clostridioides difficileWhole-genome Sequencing Differentiates Relapse With the Same Strain From Reinfection With a New Strain
- 17 February 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 72 (5) , 806-813
Abstract
Current approaches in tracking Clostridioides difficile infection (CDI) and individualizing patient management are incompletely defined. We recruited 468 subjects with CDI at Mayo Clinic Rochester between May and December 2016 and performed whole-genome sequencing (WGS) on C. difficile isolates from 397. WGS was also performed on isolates from a subset of the subjects at the time of a recurrence of infection. The sequence data were analyzed by determining core genome multilocus sequence type (cgMLST), with isolates grouped by allelic differences and the predicted ribotype. There were no correlations between C. difficile isolates based either on cgMLST or ribotype groupings and CDI outcome. An epidemiologic assessment of hospitalized subjects harboring C. difficile isolates with ≤2 allelic differences, based on standard infection prevention and control assessment, revealed no evidence of person-to-person transmission. Interestingly, community-acquired CDI subjects in 40% of groups with ≤2 allelic differences resided within the same zip code. Among 18 subjects clinically classified as having recurrent CDI, WGS revealed 14 with initial and subsequent isolates differing by ≤2 allelic differences, suggesting a relapse of infection with the same initial strain, and 4 with isolates differing by >50 allelic differences, suggesting reinfection. Among the 5 subjects classified as having a reinfection based on the timing of recurrence, 3 had isolates with ≤2 allelic differences between them, suggesting a relapse, and 2 had isolates differing by >50 allelic differences, suggesting reinfection. Our findings point to potential transmission of C. difficile in the community. WGS better differentiates relapse from reinfection than do definitions based on the timing of recurrence.Keywords
Funding Information
- National Institutes of Health (DK114007)
- Mayo Clinic
This publication has 31 references indexed in Scilit:
- Health Care–Associated InfectionsJAMA Internal Medicine, 2013
- Clostridium difficilesurveillance: harnessing new technologies to control transmissionExpert Review of Anti-infective Therapy, 2013
- Epidemiology of Clostridium difficile Infection and Risk Factors for Unfavorable Clinical Outcomes: Results of a Hospital-Based Study in Barcelona, SpainJournal of Clinical Microbiology, 2013
- Updating benchtop sequencing performance comparisonNature Biotechnology, 2013
- Relationship Between Bacterial Strain Type, Host Biomarkers, and Mortality in Clostridium difficile InfectionClinical Infectious Diseases, 2013
- Lack of Association between Clinical Outcome of Clostridium difficile Infections, Strain Type, and Virulence-Associated PhenotypesJournal of Clinical Microbiology, 2011
- Host and Pathogen Factors forClostridium difficileInfection and ColonizationNew England Journal of Medicine, 2011
- Fourteen-Genome Comparison Identifies DNA Markers for Severe-Disease-Associated Strains of Clostridium difficileJournal of Clinical Microbiology, 2011
- Clinical Risk Factors for Severe Clostridium difficile –associated DiseaseEmerging Infectious Diseases, 2009
- Comparison of Real-Time PCR for Detection of the tcdC Gene with Four Toxin Immunoassays and Culture in Diagnosis of Clostridium difficile InfectionJournal of Clinical Microbiology, 2008